Reprogramming of PD1+M2-like tumor-associated macrophages with anti-PD-L1 and Lenalidomide in cutaneous T cell lymphoma.

被引:0
|
作者
Han, Zhen [1 ,5 ]
Su, Chingyu [1 ,5 ]
Wu, Xiwei [2 ,5 ]
Qin, Hanjun [2 ,5 ]
Rosen, Steven T. [3 ,5 ]
Querfeld, Christiane [1 ,3 ,4 ,5 ]
机构
[1] Div Dermatol, Duarte, CA USA
[2] Dept Mol & Cellular Biol, Duarte, CA USA
[3] Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA
[4] Dept Pathol, Duarte, CA USA
[5] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2759
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Reprogramming of PD-1+M2-like tumor-associated macrophages with anti-PD-L1 and lenalidomide in cutaneous T cell lymphoma
    Han, Zhen
    Wu, Xiwei
    Qin, Hanjun
    Yuan, Yate-Ching
    Schmolze, Daniel
    Su, Chingyu
    Zain, Jasmine
    Moyal, Lilach
    Hodak, Emmilia
    Sanchez, James F.
    Lee, Peter P.
    Feng, Mingye
    Rosen, Steven T.
    Querfeld, Christiane
    JCI INSIGHT, 2023, 8 (13)
  • [2] Reprogramming of tumor-associated macrophages with anti-PD-L1 & lenalidomide in cutaneous T cell lymphoma
    Han, Z.
    Su, C.
    Wu, X.
    Qin, H.
    Gunes, E.
    Rosen, S.
    Querfeld, C.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S119 - S119
  • [3] Anti-PD-L1 and lenalidomide enhance anti-tumor immunity in cutaneous T cell lymphoma through targeting PD1+M2-like tumor-associated macrophages
    Querfeld, Christiane
    Wu, Xiwei
    Qin, Hanjun
    Yuan, Yate-Ching
    Su, Chingyu
    Zain, Jasmine
    Feng, Mingye
    Rosen, Steven
    Han, Zhen
    EUROPEAN JOURNAL OF CANCER, 2023, 190 : S4 - S4
  • [4] Functional remodeling of macrophages with anti-PD-L1 and lenalidomide in cutaneous T cell lymphoma
    Han, Zhen
    Su, Ching-Yu
    Wu, Xiwei
    Qin, Hanjun
    Zain, Jasmine
    Rosen, Steven T.
    Querfeld, Christiane
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : S15 - S15
  • [5] Anti-PD-L1 mAb reduces tumor growth in a mouse model of cutaneous T cell lymphoma
    Wu, X.
    Wang, K.
    Hwang, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S47 - S47
  • [6] Preliminary Analysis Demonstrates Durvalumab (Anti-PD-L1) & Lenalidomide Is Superior to Single-Agent Durvalumab (anti-PD-L1) in Refractory/Advanced Cutaneous T Cell Lymphoma in a Randomized Phase 2 Trial
    Querfeld, Christiane
    Chen, Lu
    Wu, Xiwei
    Han, Zhen
    Su, ChingYu
    Banez, Melissa
    Quach, Jeralyn
    Barnhizer, Tiffanie
    Crisan, Liliana
    Rosen, Steven T.
    Zain, Jasmine M.
    BLOOD, 2023, 142
  • [7] Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers
    Hao Zhang
    Lin Liu
    Jinbo Liu
    Pengyuan Dang
    Shengyun Hu
    Weitang Yuan
    Zhenqiang Sun
    Yang Liu
    Chengzeng Wang
    Molecular Cancer, 22
  • [8] Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers
    Zhang, Hao
    Liu, Lin
    Liu, Jinbo
    Dang, Pengyuan
    Hu, Shengyun
    Yuan, Weitang
    Sun, Zhenqiang
    Liu, Yang
    Wang, Chengzeng
    MOLECULAR CANCER, 2023, 22 (01)
  • [9] Tumor-Associated Macrophages Regulate PD-1/PD-L1 Immunosuppression
    Pu, Yunzhou
    Ji, Qing
    FRONTIERS IN IMMUNOLOGY, 2022, 13